Sushentsev N, Hamm G, Richings J, McLean MA, et al. Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence. Proc Natl Acad Sci U S A 2023;120:e2312261120.
PMID: 38011568